Association of Complete Blood Count -Derived Inflammatory Markers Indices with Renal Function in Patients with Chronic Kidney Disease: A Case–Control Study from Basrah, Iraq

Main Article Content

Raghad jassem

Abstract

Chronic kidney disease (CKD) is defined as progressive deterioration of renal function, with persistent activation of inflammatory pathways contributing to disease progression and complications. Although traditional inflammatory markers are useful, their routine application is often limited by high costs and accessibility issues. Recently, complete blood count (CBC)-derived inflammatory indices, including neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), and systemic inflammation response index (SIRI), have emerged as simple, inexpensive, and readily available biomarkers of systemic inflammatory status. However, the relationship between these indices and renal function across different populations remains poorly understood. This case–control study aimed to evaluate the association between CBC-derived inflammatory indices and renal function in patients with CKD. A total of 166 subjects were enrolled, comprising 78 patients with CKD and 88 healthy controls. Routine hematological parameters, serum urea, creatinine, and estimated glomerular filtration rate (eGFR) were assessed, and inflammatory indices were calculated from CBC-derived data. Statistical tests were used to compare groups, while Spearman correlation and multivariable linear regression analyses were employed to explore associations between indices and kidney function. Serum levels of urea, creatinine, NLR, and SIRI were significantly higher in CKD patients compared to healthy controls, whereas eGFR values were markedly decreased (all P < 0.001). eGFR showed strong inverse correlations with creatinine and urea, as well as significant negative associations with NLR and SIRI. Conversely, SII did not differ significantly between groups (P > 0.05); however, in multivariable analysis, SII remained independently associated with eGFR, suggesting a potential relationship with renal function beyond group-level differences. Among the evaluated inflammatory indices, SIRI demonstrated the most consistent and robust association with impaired renal function. These findings suggest that CBC-derived inflammatory indices, particularly SIRI, may serve as affordable and accessible biomarkers for assessing systemic inflammation and renal dysfunction in CKD. When integrated with conventional renal parameters, they could enhance clinical risk assessment and disease monitoring. Nevertheless, further validation through large-scale, multicenter prospective studies is warranted to confirm these findings and establish their clinical utility.

Article Details

How to Cite
jassem, R. (2026). Association of Complete Blood Count -Derived Inflammatory Markers Indices with Renal Function in Patients with Chronic Kidney Disease: A Case–Control Study from Basrah, Iraq. Libyan Journal of Medical and Applied Sciences, 123–132. https://doi.org/10.64943/ljmas.2026.040311
Section
Articles

References

Ma, Y., et al., Systemic immune inflammatory index and mortality in chronic kidney disease. Frontiers in Endocrinology, 2025. Volume 16 - 2025.

Huang, P., et al., Association of systemic immune-inflammation index and systemic inflammation response index with chronic kidney disease: observational study of 40,937 adults. Inflammation Research, 2024. 73(4): p. 655-667.

Elangovan, D., et al., Association of NLR, MLR, PLR, SII, and SIRI with the stages of chronic kidney disease-A cross-sectional study. 2024.

Silva, A.J.d., et al., Pediatric chronic kidney disease: blood cell count indexes as inflammation markers. Brazilian Journal of Nephrology, 2023. 45(4): p. 458-469.

Li, X., L. Cui, and H. Xu, Association between systemic inflammation response index and chronic kidney disease: a population-based study. Front Endocrinol (Lausanne), 2024. 15: p. 1329256.

Choromzade, S., et al., Comparison of complete blood count (CBC) parameters in patients with Sanjad-sakati syndrome and healthy controls in Abuzar Hospital, Ahvaz. European Journal of Pediatrics, 2026. 185(7): p. 532.

Aghaei, M., et al., Evaluation of Complete Blood Count Parameters in Patients With Diabetes Mellitus: A Systematic Review. Health Science Reports, 2025. 8(2): p. e70488.

Chen, Y., et al., Association between systemic inflammatory indicators with the survival of chronic kidney disease: a prospective study based on NHANES. Front Immunol, 2024. 15: p. 1365591.

Graterol Torres, F., et al., Evolving Concepts on Inflammatory Biomarkers and Malnutrition in Chronic Kidney Disease. Nutrients, 2022. 14(20).

Gao, W., et al., Progress in the application of novel inflammatory indicators in chronic kidney disease. Front Med (Lausanne), 2025. 12: p. 1500166.

Stenvinkel, P. and M. Suliman, Contribution of Inflammation to Vascular Disease in Chronic Kidney Disease Patients. Saudi Journal of Kidney Diseases and Transplantation, 2008. 19(3): p. 329-345.

Amalia, A., EGFR Calculator: Panduan Komprehensif Navigasi Kesehatan Ginjal. 2026: Afdan Rojabi Publisher.

Zahorec, R., Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl Lek Listy, 2021. 122(7): p. 474-488.

Wu, Y., et al., Systemic immune-inflammation index as a versatile biomarker in autoimmune disorders: insights from rheumatoid arthritis, lupus, and spondyloarthritis. Frontiers in Immunology, 2025. Volume 16 - 2025.

Marchi, F., et al., Systemic Immune-Inflammation Index and Systemic Inflammatory Response Index as Predictors of Mortality in ST-Elevation Myocardial Infarction. J Clin Med, 2024. 13(5).

Li, S., et al., Systemic Inflammation Response Index (SIRI), cancer stem cells and survival of localised gastric adenocarcinoma after curative resection. J Cancer Res Clin Oncol, 2017. 143(12): p. 2455-2468.

Gao, W., et al., Progress in the application of novel inflammatory indicators in chronic kidney disease. Frontiers in Medicine, 2025. Volume 12 - 2025.

Oliveras, L., et al., KDIGO Life Cycle of Guideline Development Series–Part 3: Evidence synthesis for Guideline Development: The KDIGO Approach. Kidney International, 2026.

Li, M.-J., et al., Global burden of chronic kidney disease and its attributable risk factors (1990-2021): an analysis based on the global burden of disease study. Frontiers in endocrinology, 2025. 16: p. 1563246.

Templeton, A.J., et al., Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Journal of the National Cancer Institute, 2014. 106(6): p. dju124.

Webster, A.C., et al., Chronic kidney disease. The lancet, 2017. 389(10075): p. 1238-1252.

Li, X., L. Cui, and H. Xu, Association between systemic inflammation response index and chronic kidney disease: a population-based study. Frontiers in Endocrinology, 2024. 15: p. 1329256.

Zhang, F., et al., The systemic immune-inflammation index and systemic inflammation response index are useful for predicting mortality in patients with diabetic nephropathy. Diabetology & Metabolic Syndrome, 2024. 16(1): p. 282.

Anders, H.-J., et al., CKD therapy to improve outcomes of immune-mediated glomerular diseases. Nephrology Dialysis Transplantation, 2023. 38(Supplement_2): p. ii50-ii57.

Kurts, C., et al., The immune system and kidney disease: basic concepts and clinical implications. Nature Reviews Immunology, 2013. 13(10): p. 738-753.

Mojtahedi, S.Y., et al., Association between systemic immune-inflammation index and risk of chronic kidney disease, a systematic review and meta-analysis. 2025.

Tanaka, M., Á. Szabó, and L. Vécsei, Redefining roles: A paradigm shift in tryptophan–kynurenine metabolism for innovative clinical applications. International journal of molecular sciences, 2024. 25(23): p. 12767.

Baaten, C.C., et al., Platelet function in CKD: a systematic review and meta-analysis. Journal of the American Society of Nephrology, 2021. 32(7): p. 1583-1598.

Baaten, C.C., et al., Platelet abnormalities in CKD and their implications for antiplatelet therapy. Clinical Journal of the American Society of Nephrology, 2022. 17(1): p. 155-170.

Gu, L., et al., Systemic inflammatory response index (SIRI) is associated with all-cause mortality and cardiovascular mortality in population with chronic kidney disease: evidence from NHANES (2001–2018). Frontiers in immunology, 2024. 15: p. 1338025.

Ma, Y., et al., Systemic immune inflammatory index and mortality in chronic kidney disease. Frontiers in Endocrinology, 2025. 16: p. 1605543.

Li, L., et al., Association between systemic immune-inflammation index and chronic kidney disease: A population-based study. PLoS One, 2024. 19(2): p. e0292646.

Lutz, J., et al., Haemostasis in chronic kidney disease. Nephrology Dialysis Transplantation, 2014. 29(1): p. 29-40.

Yang, C.H., et al., SIRI and SII as potential biomarkers of disease activity and lupus nephritis in systemic lupus erythematosus. Front Immunol, 2025. 16: p. 1530534.

Shi, Q., et al., The systemic inflammation response index (SIRI) is associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. Archives of Medical Science: AMS, 2024. 21(4): p. 1252.